MedPath

Prediction of response to Neoadjuvant chemotherapy(bi-weeklyS1/Docetaxel therapy) in advanced gastric cancer

Not Applicable
Conditions
Gastric cancer
Registration Number
JPRN-UMIN000011521
Lead Sponsor
Yokohama City University School of Medicine Department of Gastroenterological Surgery
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

Patients with severe comorbidity

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Responce rate of neoadjuvant chemotherapy
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath